PDCO - Patterson Companies, Inc.
NASDAQ
->
Healthcare
->
Medical Distribution
Saint Paul,
United States
Type: Equity
PDCO price evolution
PDCO
| (in millions $) | 30 Jul 2024 | 27 Feb 2024 | 28 Nov 2023 | 30 Oct 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $124 | $113.89 | ||
| Short term investments | ||||
| Net receivables | $484.53 | $490.43 | $408.93 | |
| Inventory | $902.73 | $858.03 | $912.67 | |
| Total current assets | $1832.56 | $1790.68 | $1772.14 | |
| Long term investments | $164.46 | $162.53 | ||
| Property, plant & equipment | $334.52 | $320.51 | $320.57 | |
| Goodwill & intangible assets | $359.59 | $368.35 | ||
| Total noncurrent assets | $1107.39 | $1099.01 | ||
| Total investments | $164.46 | $162.53 | ||
| Total assets | $2939.95 | $2889.69 | $2883.63 | |
| Current liabilities | ||||
| Accounts payable | $683.3 | $688.69 | $717.43 | |
| Deferred revenue | ||||
| Short long term debt | $366.26 | $236.13 | ||
| Total current liabilities | $1283.71 | $1148.54 | $1087.75 | |
| Long term debt | $448.22 | $449.97 | $450.6 | |
| Total noncurrent liabilities | $684.07 | $686.06 | ||
| Total debt | $894.98 | $760.5 | ||
| Total liabilities | $1968.47 | $1835.39 | $1773.29 | |
| Shareholders' equity | ||||
| Retained earnings | $802.88 | $902.83 | $948.73 | |
| Other shareholder equity | -$86.16 | -$98.96 | -$81.63 | |
| Total shareholder equity | $971.48 | $1054.3 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $159.67 | $142.01 | $143.24 | $77.94 |
| Short term investments | ||||
| Net receivables | $599.1 | $585.97 | $673.21 | $631.44 |
| Inventory | $795.07 | $785.6 | $736.78 | $812.19 |
| Total current assets | $1783.14 | $1679.02 | $1615.93 | $1542.77 |
| Long term investments | $160.02 | $139.18 | ||
| Property, plant & equipment | $305.24 | $283.86 | $296.65 | $382.75 |
| Goodwill & intangible assets | $388.29 | $393.24 | $419.58 | $452.23 |
| Total noncurrent assets | $1096.01 | $1062.61 | $1135.58 | $1172.59 |
| Total investments | $160.02 | $139.18 | ||
| Total assets | $2879.15 | $2741.63 | $2751.51 | $2715.35 |
| Current liabilities | ||||
| Accounts payable | $724.99 | $681.32 | $609.26 | $862.09 |
| Deferred revenue | ||||
| Short long term debt | $109.39 | $58.35 | $186 | $30.71 |
| Total current liabilities | $1085.33 | $1015.67 | $1089.67 | $1074.9 |
| Long term debt | $518.61 | $531.89 | $535.86 | $637.62 |
| Total noncurrent liabilities | $675.28 | $683.33 | $697.17 | $804.01 |
| Total debt | $628 | $590.23 | $721.87 | $668.33 |
| Total liabilities | $1760.61 | $1698.99 | $1786.84 | $1878.91 |
| Shareholders' equity | ||||
| Retained earnings | $972.13 | $921.7 | $855.74 | $799.65 |
| Other shareholder equity | -$89.26 | -$81.52 | -$62.59 | -$97.04 |
| Total shareholder equity | $1117.54 | $1041.68 | $963.22 | $834.12 |
| (in millions $) | 30 Jul 2024 | 27 Feb 2024 | 28 Nov 2023 | 29 Aug 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1616.1 | $1652.77 | $1576.74 | |
| Cost of revenue | ||||
| Gross Profit | $351.01 | $339.03 | $319.06 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $280.99 | $282.12 | $280.83 | |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $14.35 | $13.5 | $9.48 | |
| Interest expense | -$11.72 | -$10.64 | $2.39 | |
| Net income | ||||
| Net income | $47.7 | $39.96 | $31.23 | |
| Income (for common shares) | ||||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $6471.47 | $6499.4 | $5912.07 | $5490.01 |
| Cost of revenue | $5098.53 | $5210.32 | $4708.94 | $4292.6 |
| Gross Profit | $1372.94 | $1289.09 | $1203.13 | $1197.41 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1096.97 | $1132.09 | $992.52 | $1094.47 |
| Total operating expenses | $1096.97 | $1132.09 | $992.52 | $1769.53 |
| Operating income | $275.97 | $157 | $210.61 | -$572.12 |
| Income from continuing operations | ||||
| EBIT | $304.76 | $288.04 | $225.09 | -$547.7 |
| Income tax expense | $63.56 | $64.54 | $44.82 | -$1.04 |
| Interest expense | $33.64 | $20.29 | $24.28 | $41.79 |
| Net income | ||||
| Net income | $207.56 | $203.21 | $155.98 | -$588.45 |
| Income (for common shares) | $207.56 | $203.21 | $155.98 | -$588.45 |
| (in millions $) | 27 Feb 2024 | 28 Nov 2023 | 29 Aug 2023 | 29 May 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $718.01 | $454.86 | $223.82 | $901.57 |
| Financing activities | ||||
| Dividends paid | -$75.02 | -$50.3 | -$25.43 | -$101.35 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$34.09 | -$13.16 | -$23.12 | -$126.48 |
| Effect of exchange rate | $0.25 | -$2.17 | $1.57 | -$2.58 |
| Change in cash and equivalents | -$35.67 | -$45.79 | -$51.1 | $17.66 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $207.56 | $203.21 | $155.98 | -$588.45 |
| Operating activities | ||||
| Depreciation | $83.7 | $81.99 | $78.9 | $82.18 |
| Business acquisitions & disposals | $965.63 | $1193.7 | $833.96 | $540.94 |
| Stock-based compensation | $15.54 | $23.8 | $30.49 | $37.35 |
| Total cash flows from operations | -$754.85 | -$980.99 | -$730.52 | -$243.54 |
| Investing activities | ||||
| Capital expenditures | -$64.22 | -$38.31 | -$25.79 | -$41.81 |
| Investments | -$15 | $75.94 | ||
| Total cash flows from investing | $901.57 | $1239.03 | $810.66 | $499.13 |
| Financing activities | ||||
| Dividends paid | -$101.35 | -$101.11 | -$75.18 | -$100.44 |
| Sale and purchase of stock | -$55.49 | -$35 | ||
| Net borrowings | $14.5 | -$124.75 | $53 | -$164.14 |
| Total cash flows from financing | -$126.48 | -$253.23 | -$22.64 | -$271.23 |
| Effect of exchange rate | -$2.58 | -$6.03 | $7.8 | -$2.06 |
| Change in cash and equivalents | $17.66 | -$1.23 | $65.3 | -$17.7 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.58 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |